NASDAQ : MENS
Jyong Biotech Ltd. — Financial statements
Healthcare · Biotechnology · Taiwan
Last price 1.88 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 139.56M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 1.79M | 1.79M | 1.13M | 1.73M | 1.54M | 845.00K |
| Research & Development | 813.00K | 813.00K | 927.00K | 1.07M | 1.29M | 1.56M |
| Operating Expenses | 2.61M | 2.61M | 2.06M | 2.80M | 2.83M | 2.40M |
| Operating Income | -2.61M | -2.61M | -2.06M | -2.80M | -2.83M | -2.40M |
| Interest Expense | -2.54M | -2.54M | -1.03M | -757.00K | -765.00K | -835.00K |
| Interest & Investment Income | 610.00K | 610.00K | 7.00K | 56.00K | 5.00K | 6.00K |
| Other Non Operating Income (Expenses) | -130.00K | -130.00K | 70.00K | -816.00K | -3.04M | -965.00K |
| EBT Excluding Unusual Items | -4.67M | -4.67M | -3.01M | -4.31M | -6.63M | -4.20M |
| Legal Settlements | -5.00K | -5.00K | -5.00K | -86.00K | ||
| Pretax Income | -4.67M | -4.67M | -3.02M | -4.40M | -6.63M | -4.20M |
| Net Income | -4.67M | -4.67M | -3.02M | -4.40M | -6.63M | -4.20M |
| Net Income to Common | -4.67M | -4.67M | -3.02M | -4.40M | -6.63M | -4.20M |
| Shares Outstanding (Basic) | 73.01M | 73.01M | 71.57M | 71.57M | 71.57M | 71.57M |
| Shares Outstanding (Diluted) | 73.01M | 73.01M | 71.57M | 71.57M | 71.57M | 71.57M |
| EPS (Basic) | -0.06 | -0.06 | -0.04 | -0.06 | -0.09 | -0.06 |
| EPS (Diluted) | -0.06 | -0.06 | -0.04 | -0.06 | -0.09 | -0.06 |
| Free Cash Flow | -3.04M | -3.04M | -3.62M | -2.60M | -3.22M | -2.12M |
| Free Cash Flow Per Share | -0.04 | -0.04 | -0.05 | -0.04 | -0.04 | -0.03 |
| EBITDA | -2.51M | -2.51M | -1.94M | -2.67M | -2.71M | -2.28M |
| D&A For EBITDA | 100.00K | 100.00K | 120.00K | 127.00K | 123.00K | 122.00K |
| EBIT | -2.61M | -2.61M | -2.06M | -2.80M | -2.83M | -2.40M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.18M | 1.18M | 98.00K | 177.00K | 718.00K | 551.00K |
| Short-Term Investments | 94.00K | 1.83M | ||||
| Cash & Short-Term Investments | 1.18M | 1.18M | 98.00K | 177.00K | 812.00K | 2.38M |
| Receivables | 13.51M | 13.51M | ||||
| Prepaid Expenses | 854.00K | 854.00K | 105.00K | 97.00K | 95.00K | 263.00K |
| Restricted Cash | 3.00K | 3.00K | 3.00K | 1.56M | 1.56M | |
| Total Current Assets | 15.54M | 15.54M | 206.00K | 1.84M | 2.46M | 2.65M |
| Property, Plant & Equipment | 3.15M | 3.15M | 3.19M | 3.54M | 6.00M | 6.78M |
| Long-Term Deferred Charges | 934.00K | 721.00K | 276.00K | |||
| Other Long-Term Assets | 2.08M | 2.08M | 2.04M | 2.14M | 7.00K | 8.00K |
| Total Assets | 20.78M | 20.78M | 6.37M | 8.25M | 8.74M | 9.43M |
| Accounts Payable | 2.00K | 2.00K | 3.00K | 2.00K | 4.00K | 46.00K |
| Accrued Expenses | 22.90M | 22.90M | 1.32M | 1.14M | 863.00K | 1.06M |
| Short-Term Debt | 7.71M | 7.71M | 7.22M | 7.90M | 7.17M | 4.76M |
| Current Portion of Long-Term Debt | 571.00K | 571.00K | 57.00K | 75.00K | 479.00K | 175.00K |
| Current Portion of Leases | 81.00K | 81.00K | 159.00K | 130.00K | 170.00K | 250.00K |
| Other Current Liabilities | 3.55M | 3.55M | 3.37M | 5.01M | 4.22M | 2.00K |
| Total Current Liabilities | 34.81M | 34.81M | 12.13M | 14.26M | 12.91M | 6.29M |
| Long-Term Debt | 10.16M | 10.16M | 10.68M | 8.52M | 6.32M | 6.26M |
| Long-Term Leases | 26.00K | 26.00K | 16.00K | 69.00K | 115.00K | 346.00K |
| Other Long-Term Liabilities | 688.00K | 688.00K | 20.06M | 19.47M | 19.04M | 19.86M |
| Total Liabilities | 45.68M | 45.68M | 42.88M | 42.32M | 38.38M | 32.76M |
| Common Stock | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Additional Paid-In Capital | 28.53M | 28.53M | 11.80M | 11.80M | 11.80M | 11.80M |
| Retained Earnings | -37.75M | -37.75M | -33.08M | -30.06M | -25.66M | -19.03M |
| Treasury Stock | -16.37M | -16.37M | -16.37M | -16.37M | -16.37M | -16.37M |
| Comprehensive Income & Other | 682.00K | 682.00K | 1.12M | 548.00K | 590.00K | 266.00K |
| Shareholders' Equity | -24.91M | -24.91M | -36.52M | -34.07M | -29.63M | -23.32M |
| Total Liabilities & Equity | 20.78M | 20.78M | 6.37M | 8.25M | 8.74M | 9.43M |
| Total Debt | 18.55M | 18.55M | 18.14M | 16.69M | 14.25M | 11.79M |
| Net Cash (Debt) | -17.37M | -17.37M | -18.04M | -16.51M | -13.44M | -9.40M |
| Net Cash Per Share | -0.24 | -0.24 | -0.25 | -0.23 | -0.19 | -0.13 |
| Filing Date Shares Outstanding | 74.23M | 74.23M | 74.23M | 71.57M | 71.57M | 71.57M |
| Total Common Shares Outstanding | 74.23M | 74.23M | 71.57M | 71.57M | 71.57M | 71.57M |
| Working Capital | -19.27M | -19.27M | -11.92M | -12.42M | -10.44M | -3.65M |
| Book Value Per Share | -0.34 | -0.34 | -0.51 | -0.48 | -0.41 | -0.33 |
| Tangible Book Value | -24.91M | -24.91M | -36.52M | -34.07M | -29.63M | -23.32M |
| Tangible Book Value Per Share | -0.34 | -0.34 | -0.51 | -0.48 | -0.41 | -0.33 |
| Land | 995.00K | 995.00K | 952.00K | 1.02M | 1.02M | 1.13M |
| Buildings | 2.59M | 2.59M | 2.48M | 2.65M | 2.64M | 2.93M |
| Machinery | 964.00K | 964.00K | 922.00K | 988.00K | 984.00K | 1.06M |
| Construction In Progress | 140.00K | 140.00K | 135.00K | 139.00K | 144.00K | 33.00K |
| Leasehold Improvements | 146.00K | 146.00K | 140.00K | 150.00K | 150.00K | 67.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -4.67M | -4.67M | -3.02M | -4.40M | -6.63M | -4.20M |
| Depreciation & Amortization | 100.00K | 100.00K | 120.00K | 127.00K | 123.00K | 122.00K |
| Loss (Gain) From Sale of Investments | -3.00K | -3.00K | ||||
| Other Operating Activities | -19.20M | -19.20M | 761.00K | 554.00K | 599.00K | 849.00K |
| Change in Accounts Payable | -1.00K | -1.00K | 1.00K | -2.00K | -28.00K | 21.00K |
| Change in Other Net Operating Assets | 20.74M | 20.74M | -1.49M | 1.12M | 2.96M | 1.22M |
| Operating Cash Flow | -3.04M | -3.04M | -3.62M | -2.60M | -2.97M | -1.98M |
| Capital Expenditures | -246.00K | -137.00K | ||||
| Investment in Securities | 3.00K | 3.00K | 95.00K | 1.64M | -1.17M | |
| Other Investing Activities | -13.51M | -13.51M | ||||
| Investing Cash Flow | -13.51M | -13.51M | 95.00K | 1.39M | -1.31M | |
| Short-Term Debt Issued | 23.10M | 23.10M | 9.24M | 9.80M | 11.34M | 5.62M |
| Long-Term Debt Issued | 1.38M | 1.38M | 2.43M | 2.03M | 937.00K | 20.00K |
| Total Debt Issued | 24.47M | 24.47M | 11.67M | 11.83M | 12.28M | 5.64M |
| Short-Term Debt Repaid | -22.94M | -22.94M | -9.39M | -9.11M | -8.38M | -5.57M |
| Long-Term Debt Repaid | -1.56M | -1.56M | -71.00K | -243.00K | -291.00K | -1.45M |
| Total Debt Repaid | -24.50M | -24.50M | -9.46M | -9.36M | -8.67M | -7.02M |
| Net Debt Issued (Repaid) | -24.00K | -24.00K | 2.20M | 2.47M | 3.61M | -1.38M |
| Issuance of Common Stock | 17.77M | 17.77M | ||||
| Other Financing Activities | -114.00K | -114.00K | -213.00K | -445.00K | -276.00K | |
| Financing Cash Flow | 17.63M | 17.63M | 1.99M | 2.03M | 3.33M | -1.38M |
| Foreign Exchange Rate Adjustments | -8.00K | -8.00K | -7.00K | -54.00K | -31.00K | 67.00K |
| Net Cash Flow | 1.08M | 1.08M | -1.64M | -532.00K | 1.72M | -4.61M |
| Free Cash Flow | -3.04M | -3.04M | -3.62M | -2.60M | -3.22M | -2.12M |
| Free Cash Flow Per Share | -0.04 | -0.04 | -0.05 | -0.04 | -0.04 | -0.03 |
| Levered Free Cash Flow | 4.39M | 4.39M | -1.73M | -1.04M | 220.75K | -13.38K |
| Unlevered Free Cash Flow | 5.97M | 5.97M | -1.08M | -565.12K | 698.88K | 508.50K |
| Cash Interest Paid | 337.00K | 337.00K | 223.00K | 104.00K | 162.00K | 106.00K |
| Change in Working Capital | 20.73M | 20.73M | -1.49M | 1.12M | 2.94M | 1.24M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 138.07M | 303.76M | ||||
| Enterprise Value | 155.45M | 321.79M | ||||
| Last Close Price | 1.88 | 3.95 | ||||
| PB Ratio | -12.20 | |||||
| Debt / Equity Ratio | -0.74 | -0.74 | -0.50 | -0.49 | -0.48 | -0.51 |
| Net Debt / Equity Ratio | -0.70 | -0.70 | -0.49 | -0.48 | -0.45 | -0.40 |
| Net Debt / EBITDA Ratio | -6.93 | -6.93 | -9.32 | -6.18 | -4.97 | -4.12 |
| Net Debt / FCF Ratio | -5.71 | -5.71 | -4.98 | -6.35 | -4.18 | -4.43 |
| Quick Ratio | 0.03 | 0.03 | 0.01 | 0.01 | 0.06 | 0.38 |
| Current Ratio | 0.45 | 0.45 | 0.02 | 0.13 | 0.19 | 0.42 |
| Return on Assets (ROA) | -12.01% | -12.01% | -17.59% | -20.57% | -19.45% | -13.49% |
| Return on Capital Employed (ROCE) | 18.60% | 18.60% | 35.70% | 46.50% | 68.00% | -76.60% |
| Earnings Yield | -3.44% | -1.54% | ||||
| FCF Yield | -2.18% | -1.00% | ||||
| Buyback Yield / Dilution | -2.02% | -2.02% |